Andrew Avarbock, M.D., PH.D.
Dermatology · New York, NY
Andrew Avarbock, M.D., PH.D. is a dermatology in New York, NY with about 18 yrs in practice.
- SpecialtyDermatology
- Medical schoolPERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA (2008)
- TelehealthNot reported
- Practice size32 clinicians
- Medicare assignmentAccepts assignment (Medicare-approved amount as full payment)
- Medicare activity~272 patients across 3,606 services, avg age 76
Common services
| Service | Medicare services | Medicare allows | |
|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,996 | $7 | See prices → |
| Destruction of precancer skin growth, 1 growth | 392 | $48 | See prices → |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 264 | $95 | See prices → |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 236 | $134 | See prices → |
| Destruction of skin growth, 1-14 growths | 201 | $107 | See prices → |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 69 | $117 | See prices → |
| Biopsy of related skin growth, first growth | 62 | $71 | See prices → |
| Simple or single drainage of skin abscess | 38 | $129 | See prices → |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 38 | $178 | See prices → |
| Complicated or multiple drainage of skin abscess | 14 | $231 | See prices → |
Source: CMS Medicare Physician & Other Practitioners and the Doctors & Clinicians National Downloadable File (most recent release). Counts reflect Original Medicare activity only and are not a measure of quality. “Medicare allows” is the Medicare fee schedule amount — not what an insured or cash patient pays; for patient prices see the linked procedure pages. Always confirm a clinician’s current details with their office.